Phone
+39 010 2896 983
Address
Via Morego, 30 16163 Genova
Research center
CCT@Morego
All Publications
2026
Milordini G., Zacco E., Masi M., Armaos A., Di Palma F., Oneto M., Gilodi M., Rupert J., Broglia L., Varignani G., Scotto M., Marotta R., Girotto S., Cavalli A., Tartaglia G.G.
Computationally-designed aptamers targeting RAD51-BRCA2 interaction impair homologous recombination and induce synthetic lethality
Nature Communications, vol. 17, (no. 1)
Article
Journal
2026
Cianci F., Verduci I., Cazzoli R., Cannavale G., Rey G., Veronesi M., Balboni B., Ranucci M., Palloni L.M.G., Ballabio F., Barsotti N., Ailuno G., Balboni A., Baldassari S., Caviglioli G., Tacconi C., Camilloni C., Girotto S., Fantin A., Barbieri F., Cavalli A., Pasqualetti M., Florio T., Minucci S., Mazzanti M.
Correction: Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells (Journal of Experimental & Clinical Cancer Research, (2025), 44, 1, (312), 10.1186/s13046-025-03577-3)
Journal of Experimental and Clinical Cancer Research, vol. 45, (no. 1)
Erratum
Journal
2026
Rinaldi F., Franco P., Langer J. D., Girotto S., Cavalli A.
Decoding the RAD51–BRC repeats interplay in Homologous Recombination
BMM-AIC Structural Biology Meeting 2026
Poster
Conference
2025
Rinaldi F., Balboni B., Varignani G., Milordini G., Marotta R., Girotto S., Cavalli A.
An integrative structural study of RAD52, an emerging target in anticancer drug discovery
XXIX National Meeting on Medicinal Chemistry of the Italian Chemistry Society
Poster
Conference
2025
Rinaldi F., Balboni B., Girotto S., Cavalli A.
An integrative structural study of RAD52, an emerging target in anticancer drug discovery
XXIX National Meeting on Medicinal Chemistry of the Italian Chemistry Society
Poster
Conference